Brain lysates were prepared from Alzheimer’s disease (AD) brain extracts, either untreated or depleted of gauche P-tau, and added to cultured neurons on day 27 for a three-day assessment of gauche P-tau’s neurotoxic effects. Here, MAPT is linked to Alzheimer disease.